TABLE 1.
Central nuclei | Anguloid atrophy | Subs. vacuoles | Glycogen |
Amylase resistant polysaccharide | |||
---|---|---|---|---|---|---|---|
n | Subs. | Cytop. | |||||
Score | |||||||
Controls | 14 | 0.5 ± 1.0 | 0.54 ± 0.69 | 0.1 ± 0.3 | 0.7 ± 0.7 | 0.2 ± 0.4 | 0 |
Pro-ER | 13 | 1.4 ± 0.6* | 0.54 ± 0.63 | 0.3 ± 0.6 | 0.5 ± 0.8 | 0.5 ± 0.6 | 0 |
Retro-ER | 25 | 1.1 ± 0.8* | 1.26 ± 1.85* | 0.7 ± 0.8** | 0.8 ± 0.9 | 1.4 ± 0.9*** | 0.3 ± 0.6* |
Prevalence (score ≥1) | |||||||
Controls | 14 | 4 (29%) | 6 (43%) | 1 (7%) | 7 (50%) | 5 (36%) | 0 |
Pro-ER | 13 | 12 (92%)** | 6 (46%) | 3 (23%) | 4 (31%) | 7 (54%) | 0 |
Retro-ER | 25 | 21 (84%)** | 19 (76%)*** | 12 (48%)* | 13 (52%) | 21 (84%)* | 6 (24%) |
Scores are means ± s.d. Pro-ER = prospective exertional rhabdomyolysis group; Retro-ER= retrospective exertional rhabdomyolysis group; Subs. = subsarcolemmal; Cytop. = cytoplasmic.
Significantly different from controls in same column at P<0.05.
Significantly different from controls in same column at P<0.01.
Significantly different from controls in same column at P<0.001.